又融3亿元！海淀这家企业，让脑机接口离临床再近一步→

Group 1 - Recently, Zhiran Medical, a leading company in invasive brain-computer interfaces, announced the completion of a 300 million RMB A+ round financing [1] - This is the second round of financing completed by Zhiran Medical within six months, indicating strong market recognition of its technological capabilities and development potential in the invasive brain-computer interface sector [3] - The funds raised will primarily be used to advance large-scale clinical trials and iterate high-throughput flexible brain-computer interface products, accelerating the clinical application of this technology [3] Group 2 - The global brain-computer interface industry is entering a critical window for technological differentiation and clinical transformation, with invasive, semi-invasive, and non-invasive technologies showing a competitive landscape [5] - The invasive route, with its advantages in high precision, real-time data collection, and high data acquisition volume, is becoming a core breakthrough in serious medical applications and future human-computer interaction [5] - Zhiran Medical, established in 2022, focuses on developing a new generation of invasive flexible brain-computer interface platforms for precise diagnosis and treatment of neurological diseases [5][6] Group 3 - Zhiran Medical has completed a systematic layout of the invasive brain-computer interface industry chain, establishing a complete industrial closed loop from core technology research and development to large-scale production [8] - The company has made significant breakthroughs in key technologies, including flexible electrodes, neural chips, decoding algorithms, and electrode implantation robots [8] - The recent breakthrough in high-throughput flexible electrodes addresses industry challenges related to traditional linear flexible electrodes, enhancing signal acquisition and biomechanical compliance [8][10] Group 4 - The team has successfully developed a high-throughput wireless invasive brain-computer interface system based on stretchable flexible electrodes, improving biocompatibility and signal transmission bandwidth [12] - By 2025, Zhiran Medical completed the first domestic clinical implantation of an invasive brain-computer interface product with over 100 channels, initially verifying the product's safety and effectiveness [12] - The company plans to initiate large-scale registration clinical trials for the over 100-channel invasive brain-computer interface product in 2026, accelerating its clinical deployment [12]